BridgeMD
New treatment option for Speech Impairment
Official title Voiceitt for People With Impairments in Speech
ClinicalTrials.gov ID: NCT06874322
What this study is testing
- What it's testing
- The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 and older
You may be able to join if
- Age 13 or older
- moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc.
- Ability to understand and follow instructions for using the Voiceitt app.
You likely can't join if
- Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training.
- Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia.
- Severe physical impairments that prevent interaction with the app.
- Non-English speakers.
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.